Market Overview:
The global wearable autoinjector market is expected to grow at a CAGR of 10.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in wearable autoinjectors. By type, the 1-10ml drug segment is expected to account for the majority share of the global wearable autoinjector market in 2018. By application, hospitals are expected to account for the majority share of the global wearable autoinjector market in 2018.
Product Definition:
A wearable autoinjector is a medical device that can be worn on the body to automatically inject a dose of medication, such as an EpiPen, into the user. The device is typically worn on the belt or in a pocket and detects when it needs to be used by monitoring things like heart rate or blood sugar levels. When it senses that it needs to be used, it will automatically inject the medication into the user.
1-10ml Drug:
1-10ml drug is a new dosage form of injectable drugs. It’s an ideal size for subcutaneous injection and can be administered by almost all patients, including infants and the elderly. The 1-10ml drug is intended to replace the standard vial or ampoules in current commercial production as well as future wearable or portable devices that would require an injectable dose formulation.
10-20ml Drug:
The global 10-20ml drug and it's usage in wearable autoinjector market size was valued at USD 6.2 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period.
Application Insights:
Based on the application, the market is segmented into hospitals, clinics and family. The hospitals segment dominated the overall wearable autoinjector market in 2017 owing to factors such as increasing prevalence of chronic diseases such as diabetes and an aging population that require regular medication. Furthermore, government initiatives aimed at improving healthcare infrastructure are expected to drive demand for these devices in hospitals across the globe.
The clinics application segment is anticipated to witness significant growth over the forecast period due to rising awareness about preventive healthcare along with increasing incidences of infectious diseases like HIV/AIDS that requires regular antiretroviral drug therapy throughout its life cycle. This has led manufacturers towards developing advanced wearable autoinjectors with improved performance characteristics compared to their conventional counterparts at a lower cost structure which would eventually benefit end-users leading towards higher adoption rates among patients globally.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of healthcare providers and an increase in R&D investments by major players. The region is expected to maintain its dominance over the forecast period due to increasing product launches, technological advancements, and high disposable income. Europe accounted for more than 25% share of the overall revenue in 2017 owing to growing demand for autoinjectors from several countries including France, Germany, Italy among others. Asia Pacific is anticipated to witness lucrative growth during the forecast period as a result of rising incidence rates of various diseases coupled with improving healthcare infrastructure especially in developing economies such as India and China.
The key companies operating in this industry include but are not limited too; CIVCO Medical Solutions Pvt Ltd., Meditech Devices Pvt Ltd., B Braun Melsungen AG & Co.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), non-communicable diseases such as heart disease, stroke, cancer, and diabetes accounted for 63% of all deaths worldwide in 2012. This number is expected to rise to 73% by 2030. The increasing prevalence of chronic diseases will drive the demand for wearable autoinjectors in the coming years.
- Growing awareness about self-injection: There is a growing awareness among people about self-injection and its benefits over traditional methods such as oral medication or injections administered by healthcare professionals. Wearable autoinjectors offer an easy and convenient way for people to inject themselves with medications when required, without having to go through the hassle of visiting a doctor or nurse every time they need an injection dose administered orally or intravenously . This growing awareness will spur demand for wearable autoinjectors in the coming years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Wearable Autoinjector Market Research Report
By Type
1-10ml Drug, 10-20ml Drug
By Application
Hospitals, Clinics, Family
By Companies
BD Medical, Sonceboz, Ypsomed Holding, Sorrel Medical, Subcuject, Enable Injections Inc, Sensile Medical AG, Noble, Elcam3D
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global Wearable Autoinjector Market Report Segments:
The global Wearable Autoinjector market is segmented on the basis of:
Types
1-10ml Drug, 10-20ml Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Family
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD Medical
- Sonceboz
- Ypsomed Holding
- Sorrel Medical
- Subcuject
- Enable Injections Inc
- Sensile Medical AG
- Noble
- Elcam3D
Highlights of The Wearable Autoinjector Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1-10ml Drug
- 10-20ml Drug
- By Application:
- Hospitals
- Clinics
- Family
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Wearable Autoinjector Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A wearable autoinjector is a small, portable device that can automatically inject medication into a person's body when they need it. They are often used to treat conditions like diabetes, heart disease, and asthma.
Some of the major companies in the wearable autoinjector market are BD Medical, Sonceboz, Ypsomed Holding, Sorrel Medical, Subcuject, Enable Injections Inc, Sensile Medical AG, Noble, Elcam3D.
The wearable autoinjector market is expected to register a CAGR of 10.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Wearable Autoinjector Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Wearable Autoinjector Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Wearable Autoinjector Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Wearable Autoinjector Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Wearable Autoinjector Market Size & Forecast, 2020-2028
4.5.1 Wearable Autoinjector Market Size and Y-o-Y Growth
4.5.2 Wearable Autoinjector Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 1-10ml Drug
5.2.2 10-20ml Drug
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Family
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Wearable Autoinjector Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Wearable Autoinjector Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 1-10ml Drug
9.6.2 10-20ml Drug
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Family
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 1-10ml Drug
10.6.2 10-20ml Drug
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Family
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 1-10ml Drug
11.6.2 10-20ml Drug
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Family
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 1-10ml Drug
12.6.2 10-20ml Drug
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Family
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 1-10ml Drug
13.6.2 10-20ml Drug
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Family
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Wearable Autoinjector Market: Competitive Dashboard
14.2 Global Wearable Autoinjector Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD Medical
14.3.2 Sonceboz
14.3.3 Ypsomed Holding
14.3.4 Sorrel Medical
14.3.5 Subcuject
14.3.6 Enable Injections Inc
14.3.7 Sensile Medical AG
14.3.8 Noble
14.3.9 Elcam3D
